Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Name_of_Study,Research_Information_Link,Context_of_Research
1155351,"Biogen Idec Inc.",MA,100000000193,172.00,01/31/2014,"Cash or cash equivalent",198232946,"","","Long Term Safety and Efficacy Extension Study of Oral BG00012 Monotherapy in Relapsing Remitting Multiple Sclerosis","",""
